XML 81 R69.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' equity - Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2018
Options Outstanding        
Outstanding, beginning balance (in shares) 20,342,259      
Outstanding, ending balance (in shares) 18,553,783 20,342,259    
2021 Stock incentive Plan        
Options Outstanding        
Outstanding, beginning balance (in shares) 19,942,259      
Granted (in shares) 0      
Exercised (in shares) (846,284)      
Canceled (in shares) (942,192)      
Outstanding, ending balance (in shares) 18,153,783 19,942,259    
Weighted Average Exercise Price        
Outstanding, beginning balance (in USD per share) $ 9.70      
Granted (in USD per share) 0      
Exercised (in USD per share) 4.30      
Canceled (in USD per share) 13.80      
Outstanding, ending balance (in USD per share) $ 9.74 $ 9.70    
Outstanding, Weighted Average Remaining Contractual Term (in years) 7 years 5 months 12 days 8 years 1 month 20 days    
Outstanding, Aggregate Intrinsic Value $ 67,812 $ 226,350    
Vested and Expected to Vest, Awards Outstanding (in shares) 18,153,783      
Vested and Expected to Vest, Weighted Average Exercise Price (in USD per shares) $ 9.74      
Vested and Expected to Vest, Weighted Average Remaining Contractual Term (in years) 7 years 5 months 12 days      
Vested and Expected to Vest, Aggregate Intrinsic Value $ 67,812      
Exercisable, Awards Outstanding (in shares) 10,042,942      
Exercisable, Weighted Average Exercise Price (in USD per share) $ 6.00      
Exercisable, Weighted Average Remaining Contractual Term (in years) 6 years 10 months 24 days      
Exercisable, Aggregate Intrinsic Value $ 50,941      
Performance-Based Awards        
Options Outstanding        
Granted (in shares)     350,000 50,000
Performance-Based Awards | Amended and Restated 2010 Equity Incentive Plan        
Options Outstanding        
Outstanding, beginning balance (in shares) 400,000      
Granted (in shares) 0      
Exercised (in shares) 0      
Canceled (in shares) 0      
Outstanding, ending balance (in shares) 400,000 400,000    
Weighted Average Exercise Price        
Outstanding, beginning balance (in USD per share) $ 10.12      
Granted (in USD per share)      
Exercised (in USD per share)      
Canceled (in USD per share)      
Outstanding, ending balance (in USD per share) $ 10.12 $ 10.12    
Outstanding, Weighted Average Remaining Contractual Term (in years) 8 years 1 month 9 days 8 years 7 months 6 days    
Outstanding, Aggregate Intrinsic Value $ 358 $ 3,768    
Vested and Expected to Vest, Awards Outstanding (in shares) 400,000      
Vested and Expected to Vest, Weighted Average Exercise Price (in USD per shares) $ 10.12      
Vested and Expected to Vest, Weighted Average Remaining Contractual Term (in years) 8 years 1 month 9 days      
Vested and Expected to Vest, Aggregate Intrinsic Value $ 358      
Exercisable, Awards Outstanding (in shares) 182,291      
Exercisable, Weighted Average Exercise Price (in USD per share) $ 10.81      
Exercisable, Weighted Average Remaining Contractual Term (in years) 8 years 3 months 18 days      
Exercisable, Aggregate Intrinsic Value $ 52